Digital Assessments in Remote Trials: Exploring Pharma's Implementation Strategies

The integration of digital assessments, digital-enabled measures as well as novel digital biomarkers, into clinical trials has created a new era of patient-centric and decentralised trials. These tools offer the potential to gather and analyse comprehensive patient data remotely and in real-time, predict treatment outcomes more precisely, and streamline clinical trials. Yet, there are numerous considerations and challenges that must be navigated before such digital assessments can become commonplace for pharmaceutical companies and other trial sponsors.

Whether you are exploring effective strategies for implementing digital assessments in your  remote trials, or a digital health innovator looking to show pharma the value of digital assessment solutions, this session is for you!

Join us as we delve into:

• The Value of Digital Assessment Solutions for Pharma. Why should pharma be integrating digital assessments into their trial designs?
• Selection and Implementation of Digital Assessment Solutions by Pharma. Discuss key factors that should guide pharma in choosing the right digital measures for their clinical trial.
• Validation of Digital Measures. How can pharma optimise their strategies to ensure efficient and reliable validation of digital assessments?